Vesynta Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 8

Vesynta General Information

Description

Developer of a medical technology company intended to individualize drug therapy through its blood monitoring platform. The company's platform offers a system that combines robotic automation, analytical software, and machine learning to determine a patient's drug exposure, enabling healthcare providers to make data-driven decisions and personalize drug dosages for optimal treatment outcomes and reduced side effects.

Contact Information

Website
www.vesynta.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Innovation Gateway, the London Cancer Hub
  • Cotswold Road
  • London SM2 5NG
  • England, United Kingdom
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Innovation Gateway, the London Cancer Hub
  • Cotswold Road
  • London SM2 5NG
  • England, United Kingdom

Vesynta Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vesynta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
6. Accelerator/Incubator 01-May-2024 Completed Generating Revenue
5. Later Stage VC 05-Apr-2024 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
3. Grant 30-Mar-2022 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2020 Completed Startup
1. Accelerator/Incubator 01-Jan-2019 Completed Startup
To view Vesynta’s complete valuation and funding history, request access »

Vesynta Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary A Shares
To view Vesynta’s complete cap table history, request access »

Vesynta Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vesynta Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
SPARK for Innovations in Pediatrics Hub Accelerator/Incubator
BioIndustry Association Accelerator/Incubator
O2h Ventures Venture Capital Minority
SFC Capital Venture Capital Minority
Grow London Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Vesynta FAQs

  • When was Vesynta founded?

    Vesynta was founded in 2019.

  • Where is Vesynta headquartered?

    Vesynta is headquartered in London, United Kingdom.

  • What is the size of Vesynta?

    Vesynta has 10 total employees.

  • What industry is Vesynta in?

    Vesynta’s primary industry is Decision/Risk Analysis.

  • Is Vesynta a private or public company?

    Vesynta is a Private company.

  • What is Vesynta’s current revenue?

    The current revenue for Vesynta is .

  • How much funding has Vesynta raised over time?

    Vesynta has raised $308K.

  • Who are Vesynta’s investors?

    SPARK for Innovations in Pediatrics Hub, BioIndustry Association, O2h Ventures, SFC Capital, and Grow London are 5 of 8 investors who have invested in Vesynta.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process